No black box warning on record for Amikacin Sulfate

As of the latest FDA labeling reviewed, Amikacin Sulfate (AMIKACIN SULFATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Amikacin Sulfate medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS See WARNINGS box above. Aminoglycosides can cause fetal harm when administered to a pregnant woman. Aminoglycosides cross the placenta and there have been several reports of total irreversible, bilateral congenital deafness in children whose mothers received streptomycin during pregnancy. Although serious side effects to the fetus or newborns have not been reported in the treatment of pre

No black box warning on record for Amikacin Sulfate

Other warnings & precautions

WARNINGS See WARNINGS box above. Aminoglycosides can cause fetal harm when administered to a pregnant woman. Aminoglycosides cross the placenta and there have been several reports of total irreversible, bilateral congenital deafness in children whose mothers received streptomycin during pregnancy. Although serious side effects to the fetus or newborns have not been reported in the treatment of pre

Amikacin Sulfate Black Box Warning

No black box warning on record for Amikacin Sulfate

Other warnings & precautions

Amikacin Sulfate Black Box Warning

No black box warning on record for Amikacin Sulfate

Other warnings & precautions